Circulating microbial RNA and health by Wu, Ying Kit & Leung, Ross Ka Kit
1Scientific RepoRts | 5:16814 | DOI: 10.1038/srep16814
www.nature.com/scientificreports
Circulating microbial RNA and 
health
Ross Ka-Kit Leung1,2 & Ying-Kit Wu1,2
Measurement of health indicators in the blood is a commonly performed diagnostic procedure. Two 
blood studies one involving extended observations on the health of an individual by integrative 
Personal Omics Profiling (iPOP), and the other tracking the impact of Left Ventricular Assist Device 
(LVAD) placement on nine heart failure patients were examined for the association of change in 
health status with change in microbial RNA species. Decrease in RNA expression ratios of human 
to bacteria and viruses accompanying deteriorated conditions was evident in both studies. Despite 
large between-subject variations in bacterial composition before LVAD implantation among all the 
patients, on day 180 after the implantation they manifested apparent between-subject bacterial 
similarity. In the iPOP study three periods, namely, pre-respiratory syncytial virus (RSV) infection 
with normal blood glucose level, RSV infection with normal blood glucose level, and post-RSV 
infection with high blood glucose level could be defined. The upsurge of Enterobacteria phage PhiX 
174 sensu lato and Escherichia coli gene expression, in which membrane transporters, membrane 
receptors for environment signalling, carbohydrate catabolic genes and carbohydrate-active enzymes 
were enriched only throughout the second period, which suggests a potentially overlooked microbial 
response to or modulation of the host blood glucose level.
There is a long history of detection of previously known microbial RNA in blood and blood products 
in clinics using RT-PCR, pan-viral and pan-microbial microarrays. To understand the systematic pic-
ture of microbial composition and to probe potential interactions, unbiased deep sequencing RNA-seq 
is a possible solution. DNA sequencing technology improvements and an arsenal of massively paral-
lel sequencing (MPS) data processing methods and tools1–8 have opened up opportunities for “omics” 
research and services. Integrating expertise in pharmacogenomics, pathology, medical genetics, statistics 
and bioinformatics, clinically relevant interpretations for a patient’s genome have also been made9. In 
an omics profiling for an individual over a 14-month period (denoted as iPOP hereafter), Chen et al. 
observed that after RSV infection, 1) glucose levels elevated and extended for at least 90 days, 2) some 
genes involved in insulin signaling response and immune function exhibited downward trend of expres-
sion, and 3) cytokine levels elevated at day 12 after the infection without any apparent explanation10. 
Another survey that tracked nine heart failure patients before and after implanting continuous-flow 
left ventricular assist devices (LVADs) only focused on human gene expressions that promote a healthy 
immune response11, without exploring the dynamics of microbiome that might be associated with the 
change in post-operative health.
Scientific evidence is beginning to suggest that microbial footprints are more pervasive than imagined 
and microbiome were identified in body fluids12,13. Blood microbiome has been associated with infec-
tious and even chronic diseases, including rheumatoid arthritis, anemia, type 2 diabetes, neurological 
and cardiovascular diseases (reviewed by Potgieter et al.14). Potgieter et al. also suggested that the origin 
of the blood microbiome is a dormant form from the gut and argued that contamination alone cannot 
explain considerable observations made in the literature14. Blood microbiome was not studied in the 
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two large-scale microbiome initiatives15,16. Even in the second phase of Human Microbiome Project, the 
Integrative Human Microbiome Project17, blood microbiome is still missing on the agenda.
The scope of human health has widened after numerous reports on the role of microbiota in human 
health and diseases. From the two initiatives it is now evident that both the cells and genes of micro-
biota outnumber their human host’s and some of which even contribute to human survival. Although 
microbiota can be dynamically changing and vary significantly between than within individuals, the 
presence of “essential” microbial metabolic activities matter more18,19. Endogenous microbiota also play 
an important role in protecting their host from infection, even in the eyes by driving the maturation of 
CD4+T cells20 or development of diabetes21. At the other extreme, when immune selection is weak or 
absent, changes in microbiome in throat and possibly originated from gut were associated with change 
in health status22,23. Microbiota may also exert long-distance effects by the presence of their compo-
nents, for examples, encapsulated RNA24 and other small molecules (reviewed by Potgieter et al.14) in the 
blood. Wang et al. conducted an extensive study of evaluating the content of non-human RNA in blood 
components by computer simulation, biochemical, transfection, immunoprecipitation and expression 
experiments and concluded the existence of a significant fraction of circulating exogenous RNA, some 
of which may mediate cellular gene expression24. The concepts underlying the human microbiome and 
its relation to human health, disease and potential microbiome restorative therapies were reviewed by 
Khanna and Tosh25 and Round and Mazmanian26.
The two aforementioned multiple-time-point studies employed MPS for RNA analysis, also known 
as RNA sequencing (RNA-seq). The first study collected peripheral blood mononuclear cells (PBMCs) 
at 20 time points: roughly partitioned into periods of after human rhinovirus (HRV) infection and after 
respiratory syncytial virus (RSV) infection10. Although most PBMCs are lymphocytes, in which relatively 
few (if any) microbial nucleic acids can be identified, there are monocytes which constitute about 10% of 
the PBMC population in a healthy individual27. These monocytes, alongside differentiated macrophages 
and dendritic cells may contain microbial nucleic acids indicative of health status. The second study 
(denoted as LVAD hereafter) analyzed blood RNA samples drawn from the heart failure patients at 
three time points: pre-LVAD implantation, one-week and 180-day post-implantation11. These two stud-
ies together provide valuable resources for evaluating within- and between-subject metatranscriptomic 
variations for health monitoring and etiology hypotheses.
Results
Our analytical procedures were able to reveal the expression of all the 11 genes of PhiX 174 sensu lato 
with even and deep coverage for Lappalainen, T. et al.’s sequencing data28 (Supplemental Table 1). Less 
than 0.01% of the total simulated sequencing reads with 0 or 2 mismatch incorporation could not be 
mapped onto human, bovine, mouse and yeast reference RNA and these unmapped reads were mostly 
poly T or poly A sequences. For those that could be mapped, they were all mapped to the correct domain 
reference (Supplemental Table 1). For the iPOP and LVAD datasets used in this study, the percentage of 
uniqueness for the sequences assigned to non-human species was 83.92 ± 12.81% (Supplemental Table 
1).
An overview about the basic information, mapping statistics, and RNA expression ratios of human to 
bacteria (RNA human/bact), human to viruses (RNA human/virus) and human to fungi (RNA human/
fungi) at different time points of the iPOP and LVAD studies is summarized in Supplemental Table 2. The 
RNA human/fungi was constantly high (> 105) under different settings and therefore it was not further 
investigated (Fig. 1). The association of microbiome with health status is presented below at ascending 
level of details: 1) RNA expression ratios of human to bacteria and viruses; 2) community composition; 
and 3) gene catalogue.
RNA expression ratios of human to bacteria and viruses. The decrease in RNA human/bact 
over the whole iPOP study period was associated with two events: RSV infection and onset of increase 
in blood glucose level. Prior to RSV infection, RNA human/bact fluctuated at a relatively high level 
(median = 31,514, Interquartile range = 40,277) (Supplemental Table 2 and Fig. 1). After RSV infection, 
the RNA human/bact steadily maintained at about 15,000 (Interquartile range = 1,817). RNA human/
virus reached its lowest during this period (median = 214, Interquartile range = 24). When the blood glu-
cose level started to rise on day 307, RNA human/virus returned to the previous level but RNA human/
bact appeared to further drop, though statistically insignificantly. The comparison of RNA human/bact 
and RNA human/virus between the periods of day 0 until the last time point before RSV infection (day 
0 to day 255), day RSV infection detected until the last time point before the onset of high blood glu-
cose (day 289 to day 301) and after the onset of high blood glucose (day 307 to day 400) by post-hoc 
test using Mann-Whitney tests with Bonferroni correction is summarized in Supplemental Table 3. To 
evaluate whether the high RNA human/bact ratios observed for five consecutive time points after RSV 
infection was due to artifacts or contamination, we conducted a permutation test of 20 time points to 
count the occurrence of consecutive time points after random shuffling. Permutation results suggested 
that five consecutive time points displaying high RNA human/bact ratios just after RSV infection is 
not common (Supplemental Table 4). In the LVAD study, the changes of RNA human/bact and RNA 
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human/virus (Supplemental Fig. 1) agreed with the prior observations that a healthy immune response 
in patients with heart failure had only been partially restored six months following LVAD implantation11.
Community composition. Although within-subject similarity was obvious in the individual 
recruited in the iPOP study, within-subject similarity was violated for the patients in the LVAD study. 
The bacterial gene expression profiles among individuals were synchronized at 180 days post implan-
tation (Fig.  2). The cluster analysis suggests that batch effects were insignificant, or otherwise distinct 
green, red and orange clusters or branches would have been observed. The “synchronization” was due 
to introduction of new bacterial RNA species and independent of total number of bacterial RNA. For 
patients 4 and 5, the total number actually dropped but the bacterial diversity increased (Supplemental 
Table 5). All the nine patients manifested shallower rank abundance curves after operation, the longer 
Figure 1. Plots of hyperglycemia indicators, RNA expression ratios of human to microbiome, relative 
RNA abundance and gene expression level over the 14-month iPOP study. LPS: lipopolysaccharide, CAZy: 
Carbohydrate-Active Enzymes. Stage I: after HRV but before RSV infection, Stage II: after RSV infection 
until the last time point before the onset of high blood glucose. Stage III: after the onset of hyperglycemia.
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the interval the more obvious (Fig.  3). Of universal presence in all the nine patients at all the three 
time points, only the RNA species from Ralstonia, but not other potential nosocomial infectious agents 
from the genera of Micrococcus, Burkholderia, Sphingobium, Cupriavidus, Streptococcus, Pseudomonas, 
Staphylococcus and Escherichia increased significantly one-week post-operation in patients 2, 4, 6, 7 and 
8 (but it also dropped significantly in patient 3). Mapping results validated by BLAST search against the 
nucleotide sequence database nt showed that the Ralstonia RNA species were most likely from Ralstonia 
(R.) pickettii (Supplemental Table 6). The Ralstonia RNA level returned to previous values on day 180 
post-implantation.
Steep gradients of rank abundance curves were observed for the individual once infected by RSV 
(days 289–301) (Fig. 3), due to the explosive expansion of RNA species from potential gut flora, including 
those under the genera Shigella, Escherichia, Klebsiella, Enterobacter and Salmonella (approximately 12, 7, 
4, 3 and 2 folds respectively) compared to the period prior to the infection (days 0–255) (Supplemental 
Table 6). The same five bacterial genera RNA species were also significantly enriched contemporarily in 
patient 1 on 180 days post-implantation and in patients 4 and 5 before implantation. We examined the 
mapped Escherichia RNA at species level in the iPOP and LVAD studies and found that at least 96% of 
them were likely from Escherichia (E.) coli. The E. coli mapping result was also supported by best BLAST 
matches of E. coli against nt to the mapped contigs, minimizing the chance of random mapping by BWA 
(Supplemental Table 6). The number of viral RNA species followed the same trend as that observed in 
the bacterial RNA dynamics in both studies (Fig. 3).
We noticed that Enterobacteria phage PhiX 174 sensu lato comprised more than 99% of the entire 
virus identified from days 289 to 301. In contrast, no RSV was identified, as expected. Trace amount 
of RNA from the phage was first identified on day 255, followed by an upsurge until the onset of high 
blood glucose level (Fig. 1). In fact, RNA from Enterobacteria phage PRD1, Enterobacteria phage HK97, 
Enterobacteria phage GA, human adenovirus C and human herpesvirus 4 were also only detected during 
this period, though their abundance compared to that of PhiX 174 sensu lato was negligible. Steady and 
similar expression from all the eleven PhiX 174 sensu lato genes was identified (Supplemental Table 6); 
comparable to those from three independent PhiX RNA-seq datasets (see Methods and Supplemental 
Table 1). PhiX 174 sensu lato also comprised more than 99% of the entire virus identified in patient 1 180 
days post-implant and in patients 4 and 5 before implantation, and more than 89% in the other patients 
excepting patient 6 at 180 days after LVAD implantation (63.9%).
Gene catalogue. To explore possible mechanisms driving subsequent rising blood glucose after the 
over-dominance of PhiX 174 sensu lato and E. coli gene expression after RSV infection, we determined 
gene functional category enrichment by the DAVID Gene Functional Classification Tool8. During the 
periods of pre-RSV infection and high blood glucose level, only ribosomal protein transcripts were iden-
tified to be statistically significant (False Discovery Rate (FDR) < 0.05, Supplemental Table 7). Strikingly 
a large number of gene functional categories enriched during RSV infection was identified, including 
membrane transporters; membrane receptors for environment signaling; and carbohydrate catabolic pro-
cess. We were particularly interested in the genes that might have also accounted for the onset of high 
blood glucose level. The numbers of CAZyme (Supplemental Table 7), glucose- and lipopolysaccharide 
Figure 2. Hierarchical clustering of bacterial RNA at genus level from the 9 + 1 individuals at different 
time points respectively from the LVAD and iPOP studies. Green: pre-LVAD implantation, Red: 1 week 
post implantation, Orange: 180 days post implantation, Cyan: RSV infection period, Purple: non-RSV 
infection period. P1-P9: patients 1–9, wk: week, mo: month.
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(LPS)-related gene expression (Supplemental Table 8) were the highest during the RSV infection period. 
Although RNA human/bact were amongst the lowest on days 400, 307, 369 and 380, the three aforemen-
tioned gene categories were not enriched (Fig. 1).
The simultaneous enrichment in Enterobacteria phage PhiX 174 sensu lato and E. coli glucose-related 
gene expression was also identified in the LVAD study (patient 1 180 days after LVAD treatment and in 
patients 4 and 5 pre-implantation). The numbers of corresponding bacterial glucose-related gene were 
51, 45 and 34; where in other cases were almost zero (Supplemental Table 6). Similar results of LPS and 
CAZy matches and gene functional category enrichment were also obtained (Supplemental Tables 7–8).
No particular gene functional category except ribosomal protein was enhanced in R. pickettii 
expressed genes identified in the LVAD patients at one-week post-implantation (Supplemental Table 9). 
The ribosomal protein enrichment pattern tightly followed the change of total R. pickettii RNA species 
(Supplemental Table 6).
Discussion
Our findings facilitate the exploration of best practice guidelines in prophylaxis and health management 
by examining microbiome RNA expression at different levels of detail in blood/PBMC samples. The first 
level, RNA expression ratio of human to microbiome, requires the minimal specialized skills to derive 
and is the most intuitive for interpretation. The change in the ratio was associated with deteriorating 
Figure 3. Rank abundance curves based on bacterial and viral OTUs. The viral communities in iPOP 
and LVAD study was not diverse enough for niche model fitting. Since no pre-emption model was fitted 
and Zipf-Mandelbrot model was of minority in the bacterial communities, there were few non-linear 
components and one or two genera usually dominated. P1-P9: patients 1–9, wk: week, mo: month.
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health status in the iPOP and LVAD studies. The second and third levels, community composition and 
gene catalogue can serve useful clues to guide investigation of the composition of potential health mod-
ulators and effecting mechanisms.
Although human gene expression signatures of heart failure were characterized11,29,30, surprisingly 
there are few, if any, studies concurrently characterizing any microbiome altered after LVAD implanta-
tion, despite that LVAD support is associated with infections31. Reported median and maximum hospital 
length of stay of LVAD implant patients were 20 and 90 days32, therefore the significantly increased diver-
sity observed at 180 days post-implantation unlikely represented newly acquired nosocomial infections. 
A plausible explanation is nutrient availability33, which facilitates the colonization of more diverse types 
of bacteria, instead of only enabling the survival of oligotrophs, for example, the nosocomial infectious 
agent R. pickettii. Our findings indeed showed that RNA from the aerobic, motile R. pickettii increased 
significantly in five patients one week after the operation but returned to a previous level on day 180 
after implantation. The decrease in the RNA proportion of motile bacteria might also imply loss of niche 
when nutrients become more available. In addition to Ralstonia, RNA species from common nosocomial 
infectious agents Pseudomonas and Staphylococcus were also universally present in all the patients over 
the three time points. The species from these two genera are also the most common causative patho-
gens to LVAD patients31. Nevertheless, their RNA species were not significantly enriched in any single 
patient. In summary, taking the microbial components into consideration of the specific differential 
gene expressions involved in healthy immune response after LVAD placement identified by Mitchell 
et al.11 is important because the blood transcriptome dynamics might actually be the outcome of complex 
interplay between host response to subclinical infections and micro-organisms adapting varying environ-
mental conditions. To optimize the response to LVAD34, management of (subclinical) infections35 may 
play a significant role in future care of patients with end stage heart failure.
Previously unexplored connections between the onset of elevated glucose levels and microbiome were 
identified. The low RNA human/bact and RNA human/virus alone sufficed to reveal the RSV infection 
status. When bacterial community was examined, the relative abundance of E. coli RNA species was 
found to increase up to almost 80% after RSV infection (Supplemental Table 6) but E. coli is present at 
no more than one percent abundance of gut flora in healthy human stool microbiomes18. High blood 
glucose level was observed only beginning from day 307 but the gene enrichment in carbohydrate metab-
olism only lasted until day 301, exactly the day when an unexplained cytokine spike was identified10. 
Interestingly, the disappearance in gene enrichment was accompanied by significant decrease of PhiX 174 
sensu lato RNA. The same co-existence of the phage and carbohydrate metabolism was also observed in 
the LVAD study, suggesting the functional implications of the phage in the E. coli gene expression. In fact, 
PhiX 174 sensu lato A* gene can inhibit DNA replication and cell division but not beta-galactosidase36 
and possibly other genes in E. coli. The phage was likely to be active during the RSV infection period 
because steady and comparable expression of all the eleven PhiX 174 sensu lato genes was identified 
(Supplemental Table 6). Lipopolysaccharide-related gene expression of E. coli (Supplemental Table 6, 
Fig. 1) might also facilitate PhiX 174 sensu lato infection37. Moreover, naked RNA is prone to degrada-
tion38, probably due to the ubiquitous RNAse in the blood39. Chen et al. identified that immune cell and 
insulin signaling had been perturbed to some extent during the RSV infection and high glucose states of 
their study subject10. Whether the PhiX 174 sensu lato-Escherichia coli-blood glucose axis was a cause, a 
consequence or an independent event of the perturbation warrants further investigations.
The setting of this study carried several limitations. Firstly, the metatranscriptome and metagenome 
may not be related directly40. Nevertheless, once quantitative relationship between metagenomic compo-
sition and human health is established, cheaper, faster and more convenient detection method such as gel 
electrophoresis of 16S rRNA amplicons can then be performed, an approach adopted to investigate the 
association of the gut microbiota profile with insulin action in humans41. Secondly, this study does not 
allow the inference of causality. While time-series data would be ideal to reveal this, a full-fledged anal-
ysis was limited by data availability. We attempted to collect healthy controls from a public data reposi-
tory. For those datasets with accompanying publications in the Sequence Read Archive, different sample 
preparation methods have created irreversible data loss. These include filtering42, isolation and purifi-
cation of intracellular RNA only43, gene-specific amplification44 or exome capture45. Although the RNA 
expression ratios of human to bacteria among different studies were still larger than one, the variations 
were very large (Supplemental Table 10). Indeed, between-subject variations were also reported to be 
large in Human Microbiome Project18. This was also the reason why the two studies with within-subject 
blood microbiome at different time points were chosen. Thirdly, the main challenge to identify a good 
normalization method for meta-transcriptomics is complexity. A typical transcriptome study deals with 
the total mRNA of a single organism under two or more conditions. In a meta-transcriptomics study, 
there are multiple organisms which can have very different genes in character and quantity to be meas-
ured of their expression. Recently, there has been some development in normalizing RNA-sequencing 
data from samples with varying mRNA levels46 and using mixtures of biological samples as process 
controls47. However, the former still concerns only a single organism and the later assumes well defined 
mixture, which is unavailable in this study. Therefore the methods in the two aforementioned studies 
cannot be directly applied to this study. Removing unwanted variation by performing factor analysis on 
suitable sets of control genes48 is also difficult, because how to identify the set of control genes represent-
ing multiple organisms warrants rigorous research efforts. Finally, false discovery rates for enrichment 
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across species were not carried out. For meta-transcriptomics the calculation again demands special 
handling like that of normalization. In this study, there is no well-defined boundary or test-control com-
parison. When the number of combinations increases, the total number of hypothesis tests that are to 
be performed also increases accordingly. Nevertheless, there is a need to develop a rigorous assessment 
method to control false discoveries in future.
Figure 4. A schematic diagram summarizing the data analysis workflow in this study. 
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In this work, we put forward the concept of comparing circulating microbial RNA can provide insights 
into the possible mechanisms/manifestations of pathological conditions and therefore we only reported 
the most apparent differences (for example, see Fig. 1), in which the differential gene expression was up 
to 10 to 107 fold. We wish our findings would on one hand inspire experts from mathematics, statistics, 
computer science or other physical sciences to develop rigorous assessment methods and on the other 
hand generate attention in the scientific community so that more longitudinal studies (like iHMP) would 
be carried out to track the dynamics of blood microbiome and health. Plummeting sequencing cost and 
accumulated knowledge of microbiome can be exploited to add value to the relatively readily available 
blood sampling for acquiring rich and often interwoven molecular and physiological information, which 
can be analyzed for health status and health dynamics monitoring.
Methods
The methodological details of sample preparation can be found in the original published papers. Briefly, 
in the integrative personal omics profile (iPOP) study10, the molecular and physiological information 
derived from harvested peripheral blood mononuclear cells (PBMC) of a generally healthy individual 
was monitored at 20 time points over a span of 14 months. In the second study11, each of nine end 
stage heart failure patients was implanted with a left ventricular assist device (LVAD) and subjected to 
whole blood collection before and after implantation. Sequencing control lane data of PhiX 174 RNA28 
were used as data quality control in this study. RNA-seq datasets of these three studies were retrieved 
from NCBI Sequence Read Archive (SRA). The SRA accession numbers for the iPOP, LVAD and PhiX 
datasets are from SRR353635 to SRR353654; SRR846935 to SRR846959 and ERR011381, ERR011423 and 
ERR011436 respectively.
Burrows-Wheeler Aligner (BWA 0.7.8)7 was used to map sequencing reads against a reference RNA 
database compiled from the gene sequence data downloaded from Microbial Genome Database for 
Comparative Analysis (mbgd_2013–02)49, Feb. 2009 assembly of the human genome (hg19, GRCh37 
Genome Reference Consortium Human Reference 37 (patch 13)) and virus records from NCBI GenBank 
(30/06/2014 version). Mapping statistics was obtained by SAMtools (version 0.1.19)3. Trost et al. reported 
the similarity of different groups of bacteria to the human proteome50. Although the similarity may be 
lower at RNA level, uncharacterized microbiome can have similar RNA to human’s. To preclude this 
possibility, reads mapped onto either bacterial or viral genes were searched by Basic Local Alignment 
Search Tool (BLAST)51 against hg19 mRNA database again at an e-value of 1e-10. Non-specific mapping 
results were not considered in further analysis.
An expression unit modifying from fragments per kilobase of transcript per million reads mapped 
(FPKM)52 was calculated to quantify gene expression. The unit was obtained by dividing the number of 
mappable bases per gene divided by gene length and the total number of mappable bases per sample. 
Gene length information was obtained from the reference transcriptome. Human, bacterial, viral, and 
fungal RNA expression was derived by summing the total number of mapped bases in a particular 
domain (or human) per sample. The RNA expression ratios between human to bacteria (RNA human/
bact), human to viruses (RNA human/virus) and human to fungi (RNA human/fungi) could then be 
calculated.
Hierarchical clustering with multiscale bootstrap resampling was done by pvclust 1.3–253 for the bac-
terial genus RNA expression unit matrix by different samples. Correlation coefficient and average linkage 
were used and p-values were computed for each of the clusters. Since Escherichia (E.) coli gene expression 
was abundant, E. coli genes were selected as the background in the DAVID Gene Functional Classification 
Tool8 to investigate which gene functional categories were enriched. The gene mapping results from iPOP 
and LVAD studies were also searched against CAZy by dbCAN (15/03/2014 version)54. Keywords “glu-
cose”, “lipopolysaccharide”, “O-antigen” and “lipid A” were used to search the number of glucose- and 
lipopolysaccharide-related genes expressed at a particular time point. Microbiome analysis was done by 
vegan 2.1–404. Different models of Rank-Abundance Dominance at genus level were fit according to the 
Akaike Information Criterion to study the change in bacterial community richness and evenness.
To ensure our pipeline can perform sensitive and specific mapping, we employed a shotgun sequence 
simulator, Grinder55 (http://sourceforge.net/projects/biogrinder/) to generate two sets of artificial human, 
bovis, mouse and yeast transcriptome data under 0 or 2 mismatch allowance. The human, bovis and 
mouse reference gene sequences were retrieved from ftp://ftp.ncbi.nih.gov/genomes and yeast’s from The 
Saccharomyces Genome Database56. These options were based on Wang et al.’s study, which evaluated 
the content of non-human RNA in blood components taking sequencing and mapping errors into con-
sideration24. Since high RNA human/bact ratio was identified for five consecutive time points after RSV 
infection, we also conducted a permutation test of the 20 time points to count the occurrence of consec-
utive time points after random shuffling to evaluate whether the high RNA human/bact ratio observed 
was due to artifacts or contamination. The data workflow of this study is depicted in Fig. 4.
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